Cover Story
In the multi-trillion-dollar universe of biotechnology and pharmaceuticals, a world of sprawling corporate campuses, massive R&D budgets, and armies of scientists, there exists a quiet anomaly
Listing
The Antisense Architect: Dr. Stanley T. Crooke’s Legacy in Biotechnology
Dr. Stanley T. Crooke’s (Executive Chairman, Ionis Pharmaceuticals Inc.) story is one of a visionary who transformed the landscape of biotechnology. His ...
The AI Alchemist: Michelle Chen Is Writing the Code for Future Medicines
Traditional drug discovery is slow, costly, and often fails. Insilico Medicine’s Chief Business Officer, trained in biology and mentored by ...
How Morten Olesen is betting on Truth to Tame the Chaos of Modern Medicine
There’s a quiet revolution brewing in the pharmaceutical world. It doesn’t involve a blockbuster new drug or a gleaming, billion-dollar ...
Michael Rasche: Charting a New Course against Alzheimer
Michael Rasche grasps the enormous weight of his task. As Chief Executive Officer of Diadem SpA, he leads a company ...